Antisense Therapy Market - Gene Silencing and Genetic Disease Treatment
Market Overview The antisense therapy market is experiencing growth as gene-silencing technology enables treatment of genetic diseases through messenger RNA targeting. The global market is projected to exceed USD 9.5 billion through 2030, driven by genetic disease treatment, clinical approvals, and therapeutic expansion. Antisense therapy silences disease genes through targeted mRNA binding...
0 Commentaires 0 Parts 4 Vue 0 Aperçu